Calumet Inc. (NASDAQ: CLMT) is a Basic Materials company (Chemicals - Specialty) with a market capitalization of $2.8B. The Maz Rating grades it against the other companies in its sector.
About three months ago (August 17, 2026), Calumet Inc. had a Maz Rating of 4.01 out of 5 (A, Strong Buy), ranked against the other companies in its sector. Its strongest factor then was Momentum (4.99), among the strongest in its sector; its weakest was Financial Health (1.11), among the weakest in its sector. The other factors: Growth 3.72 (above most of its sector); Valuation 2.96 (valued in line with its sector); Profitability 2.78 (around the middle of its sector). The current rating is for members: log in to see it.
At $31.82, Calumet Inc. trades at 0.5x sales. Over the last twelve months it generated about $5.2B of revenue and a net loss of $198M. It runs a gross margin of 9.1%, an operating margin of 3.4% and a net margin of -3.7%. It shows return on equity of 20.5%, return on invested capital of 5.7% and a free cash flow yield of 9.5%. On the balance sheet: a debt-to-equity ratio of -2.49 and a current ratio of 1.06. Over the past 52 weeks the share price ranged from $12.94 to $59.87, with a beta of 0.78.
Calumet Inc. does not currently pay a dividend.
23 Wall Street analyst ratings cover the stock: 4 Buy, 18 Hold and 1 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.